Cognito and Ochsner join forces to explore how c
Author: Michael
As longevity biotech scales, new AI tools target
Fresh Alzheimer’s theory gives investors new l
New profiling tech looks beyond which microbes l
Longevity Medical Institute’s new paper adds w
Celosia Therapeutics announced on 23 March 2026,
C2N Diagnostics reported the first application of
Nanoscope Therapeutics announced publication of a
Annovis has partnered with NeuroRPM to deploy an
Alnylam is launching coordinated initiatives to a